About AlgoTx
AlgoTx is a company based in Suresnes (France) founded in 2018 by Stephane Thiroloix and Olivier Bohuon. It operates as a HealthTech. AlgoTx has raised $39.29 million across 4 funding rounds from investors including Bpifrance, Relyens and Omnes Capital. AlgoTx offers products and services including ATX01. AlgoTx operates in a competitive market with competitors including Flexion Therapeutics, Cara Therapeutics, Eliem Therapeutics, Ethypharm and Zogenix, among others.
- Headquarter Suresnes, France
- Founders Stephane Thiroloix, Olivier Bohuon
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$39.29 M (USD)
in 4 rounds
-
Latest Funding Round
$21.42 M (USD), Series B
Mar 14, 2023
-
Investors
Bpifrance
& 3 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of AlgoTx
AlgoTx offers a comprehensive portfolio of products and services, including ATX01. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
ATX01 is developed for complex pain relief treatment.
Unlock access to complete
Unlock access to complete
Funding Insights of AlgoTx
AlgoTx has successfully raised a total of $39.29M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $21.42 million completed in March 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series B — $21.4M
-
First Round
First Round
(01 Jun 2018)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2023 | Amount | Series B - AlgoTx | Valuation | Relyens | |
| Nov, 2020 | Amount | Series A - AlgoTx | Valuation | Bpifrance | |
| Nov, 2019 | Amount | Seed - AlgoTx | Valuation | Bpifrance |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in AlgoTx
AlgoTx has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Bpifrance, Relyens and Omnes Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm focused on energy transition and sustainable investments across Europe.
|
Founded Year | Domain | Location | |
|
UI Investissement is engaged in private equity and investment services.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by AlgoTx
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - AlgoTx
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Algotx Comparisons
Competitors of AlgoTx
AlgoTx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Flexion Therapeutics, Cara Therapeutics, Eliem Therapeutics, Ethypharm and Zogenix, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of therapies for the treatment of musculoskeletal disorders
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for pain relief and inflammatory diseases
|
|
| domain | founded_year | HQ Location |
Develops antibody-based treatments for autoimmune and inflammatory disorders.
|
|
| domain | founded_year | HQ Location |
Therapies for pain and addiction treatment are developed.
|
|
| domain | founded_year | HQ Location |
Drug delivery systems for CNS disorders and pain are developed.
|
|
| domain | founded_year | HQ Location |
Pain treatment products are developed through reformulation technologies.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Algotx
Frequently Asked Questions about AlgoTx
When was AlgoTx founded?
AlgoTx was founded in 2018.
Where is AlgoTx located?
AlgoTx is headquartered in Suresnes, France. It is registered at Suresnes, Ile-de-france, France.
Who is the current CEO of AlgoTx?
Stephane Thiroloix is the current CEO of AlgoTx. They have also founded this company.
Is AlgoTx a funded company?
AlgoTx is a funded company, having raised a total of $39.29M across 4 funding rounds to date. The company's 1st funding round was a Seed of $553.74K, raised on Jun 01, 2018.
What does AlgoTx do?
AlgoTx is engaged in the development of novel non-opioid solutions for complex pain relief. The company prioritizes indications lacking proven therapies, such as Chemotherapy-Induced Peripheral Neuropathy (CIPN) and Erythromelalgia. Its lead program, ATX01, is in Phase 2 clinical development, targeting specific patient needs through topical administration to minimize systemic side effects. Operations are based in France, with research and clinical trials conducted in the US and Europe.
Who are the top competitors of AlgoTx?
AlgoTx's top competitors include Flexion Therapeutics, Cara Therapeutics and Trevena.
What products or services does AlgoTx offer?
AlgoTx offers ATX01.
Who are AlgoTx's investors?
AlgoTx has 4 investors. Key investors include Bpifrance, Relyens, Omnes Capital, and UI Investissement.